An adeno-associated virus vector penetrates the blood–brain barrier in non-human primates | Nature Biomedical Engineering
Dissertation or Thesis | DETERMINANTS OF AAV TRANSPORT ACROSS THE BLOOD-BRAIN BARRIER | ID: v692t684w | Carolina Digital Repository
Beyond the Blood Brain Barrier: PHP.B Enters the Central Nervous System Via the LY6A Receptor
The human brain endothelial barrier: transcytosis of AAV9, transduction by AAV2
Delivering genes across the blood-brain barrier: LY6A, a novel cellular receptor for AAV-PHP.B capsids | PLOS ONE
Development of Novel Therapeutics Targeting the Blood–Brain Barrier: From Barrier to Carrier in Advanced Science-河南大学国际合作与交流处暨港澳台事务办公室
Frontiers | A Multifaceted Approach to Optimizing AAV Delivery to the Brain for the Treatment of Neurodegenerative Diseases
Crossing the blood-brain barrier with AAV vectors | SpringerLink
Delivering genes across the blood-brain barrier: LY6A, a novel cellular receptor for AAV-PHP.B capsids | PLOS ONE
Frontiers | A Multifaceted Approach to Optimizing AAV Delivery to the Brain for the Treatment of Neurodegenerative Diseases
Challenges in adeno-associated virus-based treatment of central nervous system diseases through systemic injection - ScienceDirect
Engineered AAV Vectors Cross Blood-Brain Barrier in Monkeys
AAV9: a potential blood-brain barrier buster: Molecular Therapy
Research – Gradinaru Lab
BBB-crossing adeno-associated virus vector: An excellent gene delivery tool for CNS disease treatment - ScienceDirect
Press Release August 24 2020 - STEM BIOMEDICAL
Crossing the blood-brain barrier with AAV vectors | SpringerLink
Crossing the blood-brain barrier
Rapid evolution of blood-brain-barrier-penetrating AAV capsids by RNA-driven biopanning: Molecular Therapy - Methods & Clinical Development
Reversibly Modulating the Blood–Brain Barrier by Laser Stimulation of Molecular-Targeted Nanoparticles | Nano Letters
AAV9-Retro mediates efficient transduction with axon terminal absorption and blood–brain barrier transportation | Molecular Brain | Full Text
Apolipoprotein E, low-density lipoprotein receptor, and immune cells control blood-brain barrier penetration by AAV-PHP.eB in mice
